Moors & Cabot Inc. Has $323,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Moors & Cabot Inc. trimmed its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,982 shares of the exchange traded fund’s stock after selling 340 shares during the quarter. Moors & Cabot Inc.’s holdings in SPDR S&P Biotech ETF were worth $323,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Provident Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 3,000.0% in the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after purchasing an additional 300 shares during the period. Garrison Bradford & Associates Inc. bought a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $39,000. Compass Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 46.0% in the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after buying an additional 200 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 319 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 38.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after buying an additional 200 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.0%

SPDR S&P Biotech ETF stock opened at $86.82 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The firm has a market capitalization of $4.70 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The firm’s fifty day moving average price is $84.48 and its two-hundred day moving average price is $84.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.